Case Reports
Intravenous Iron Given prior to Pregnancy for Restless Legs Syndrome is Associated with Remission of Symptoms
http://dx.doi.org/10.5664/jcsm.2168
Daniel L. Picchietti, M.D., F.A.A.S.M.1; Victor C. Wang, M.D., Ph.D.2; Matthew A. Picchietti, M.A.3
1University of Illinois School of Medicine & Carle Foundation Hospital, Urbana, IL; 2Medical Scholars Program, University of Illinois School of Medicine, Urbana, IL; 3Department of Psychology, Southern Illinois University, Carbondale, IL
Restless legs syndrome (RLS) is more common during pregnancy than in the general population, occurring at a 2-3 times higher prevalence. While iron, genetics, and central nervous system dopamine have been shown to play major roles in RLS unrelated to pregnancy, the etiology and treatment of RLS during pregnancy have not been adequately delineated. We describe a novel approach where a 23-year-old female was given intravenous iron prior to pregnancy, with complete remission of RLS symptoms until five months postpartum. Factors other than iron status that may have influenced the course of remission and relapse were oral contraceptive use, antidepressant use, and a strong family history of RLS.
Citation:
Picchietti DL; Wang VC; Picchietti MA. Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms. J Clin Sleep Med 2012;8(5):585-586.
Please login to continue reading the full article
Subscribers to JCSM get full access to current and past issues of the JCSM.
Login to JCSM
Not a subscriber?
Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership